These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
288 related items for PubMed ID: 26417813
1. Cortisol as an indicator of hypothalmic-pitituary-adrenal axis dysregulation in patients with panic disorder: a literature review. Jakuszkowiak-Wojten K, Landowski J, Wiglusz MS, Cubała WJ. Psychiatr Danub; 2015 Sep; 27 Suppl 1():S445-51. PubMed ID: 26417813 [Abstract] [Full Text] [Related]
2. HPA axis activity in patients with panic disorder: review and synthesis of four studies. Abelson JL, Khan S, Liberzon I, Young EA. Depress Anxiety; 2007 Sep; 24(1):66-76. PubMed ID: 16845643 [Abstract] [Full Text] [Related]
3. Hypothalamic-pituitary-adrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol. Abelson JL, Curtis GC. Arch Gen Psychiatry; 1996 Apr; 53(4):323-31. PubMed ID: 8634010 [Abstract] [Full Text] [Related]
4. Lack of specific association between panicogenic properties of caffeine and HPA-axis activation. A placebo-controlled study of caffeine challenge in patients with panic disorder. Masdrakis VG, Markianos M, Oulis P. Psychiatry Res; 2015 Sep 30; 229(1-2):75-81. PubMed ID: 26243374 [Abstract] [Full Text] [Related]
10. Hypothalamic-pituitary-adrenal axis activity in panic disorder: effects of alprazolam on 24 h secretion of adrenocorticotropin and cortisol. Abelson JL, Curtis GC, Cameron OG. J Psychiatr Res; 1996 Sep 30; 30(2):79-93. PubMed ID: 8816303 [Abstract] [Full Text] [Related]
11. Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects. Abelson JL, Liberzon I, Young EA, Khan S. Arch Gen Psychiatry; 2005 Jun 30; 62(6):668-75. PubMed ID: 15939844 [Abstract] [Full Text] [Related]
12. Hypothalamic-pituitary-adrenal axis activity in older persons with and without a depressive disorder. Rhebergen D, Korten NC, Penninx BW, Stek ML, van der Mast RC, Oude Voshaar R, Comijs HC. Psychoneuroendocrinology; 2015 Jan 30; 51():341-50. PubMed ID: 25462906 [Abstract] [Full Text] [Related]
19. Effects of the cortisol synthesis inhibitor metyrapone on the response to carbon dioxide challenge in panic disorder. Belgorodsky A, Knyazhansky L, Loewenthal U, Arbelle J, Cohen H, Benjamin J. Depress Anxiety; 2005 May 30; 21(3):143-8. PubMed ID: 16001448 [Abstract] [Full Text] [Related]
20. Regulation of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder. Erhardt A, Ising M, Unschuld PG, Kern N, Lucae S, Pütz B, Uhr M, Binder EB, Holsboer F, Keck ME. Neuropsychopharmacology; 2006 Nov 30; 31(11):2515-22. PubMed ID: 16841071 [Abstract] [Full Text] [Related] Page: [Next] [New Search]